CORD-19:8c51cf0cc444f6a851ad178040369984759ddfec / 17260-17442 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T140","span":{"begin":0,"end":182},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Recently, Heckenlively et al. attempted to identify subpopulations of RP patients and to determine if antiretinal antibodies are associated with selected disease processes (19, 20) ."}

{"project":"Epistemic_Statements","denotations":[{"id":"T62","span":{"begin":30,"end":182},"obj":"Epistemic_statement"}],"text":"Recently, Heckenlively et al. attempted to identify subpopulations of RP patients and to determine if antiretinal antibodies are associated with selected disease processes (19, 20) ."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T140","span":{"begin":0,"end":182},"obj":"Sentence"}],"text":"Recently, Heckenlively et al. attempted to identify subpopulations of RP patients and to determine if antiretinal antibodies are associated with selected disease processes (19, 20) ."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T65","span":{"begin":70,"end":72},"obj":"Phenotype"}],"attributes":[{"id":"A65","pred":"hp_id","subj":"T65","obj":"http://purl.obolibrary.org/obo/HP_0000510"}],"text":"Recently, Heckenlively et al. attempted to identify subpopulations of RP patients and to determine if antiretinal antibodies are associated with selected disease processes (19, 20) ."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T142","span":{"begin":70,"end":72},"obj":"Disease"},{"id":"T20750","span":{"begin":70,"end":72},"obj":"Disease"}],"attributes":[{"id":"A142","pred":"mondo_id","subj":"T142","obj":"http://purl.obolibrary.org/obo/MONDO_0008377"},{"id":"A81169","pred":"mondo_id","subj":"T20750","obj":"http://purl.obolibrary.org/obo/MONDO_0008377"}],"text":"Recently, Heckenlively et al. attempted to identify subpopulations of RP patients and to determine if antiretinal antibodies are associated with selected disease processes (19, 20) ."}